J. Scott Garland
CIK 1533228 · President and CEO · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
10
Total Filings
43
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LBRX | Director | — | $28.42 | — | $0 | 2 | 2026-06-05 |
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Director | — | $21.53 | — | $0 | 7 | 2026-04-23 |
| IMRA | Director | — | $17.02 | — | $0 | 2 | 2026-02-17 |
| ALXO | Director | — | $1.58 | — | $0 | 5 | 2026-01-21 |
| OLMA | Director | — | $9.87 | — | $0 | 3 | 2025-06-13 |
| CALA | Director | — | $0.00 | — | $0 | 3 | 2022-06-03 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | President and CEO | 1,173 | — | — | $0 | 6 | 2020-07-02 |
| KPTI | Director | — | $9.50 | — | $0 | 6 | 2019-06-07 |
| Relypsa Inc (RLYP) Delisted | SVP & Chief Commercial Officer | 16,042 | — | — | $0 | 6 | 2016-09-02 |
| EXEL | EVP & Chief Commerical Officer | — | $53.13 | — | $0 | 3 | 2013-09-19 |
Recent Filings · Page 2 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-18 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2024-05-28 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-10-17 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2023-06-26 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-22 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2022-11-29 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2022-06-23 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | CALA | Grant (A) | — | $0 | EDGAR |
| 2021-08-18 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.